Inovio Pharmaceuticals, Inc. (INO) News
Track canonical SquawkNews coverage tagged to INO, Inovio Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 16 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
INO: INO-3107 nears FDA decision, backed by strong trial data and commercial launch preparations
A proprietary DNA medicines platform is advancing toward potential approval with INO-3107 for RRP, showing strong efficacy and safety in trials. Commercial readiness is high, with a focused market strategy and robust pip
REGULATION | Sep 09, 2026, 09:12 PM UTC
L
INO: INO-3107 shows strong efficacy for RRP, with FDA decision and commercialization plans imminent
The discussion highlighted a proprietary DNA medicines platform with a lead candidate, INO-3107, nearing a pivotal FDA decision for RRP. Strong clinical efficacy, a favorable safety profile, and commercial readiness posi
REGULATION | Sep 09, 2026, 08:24 PM UTC
L
INO - INOVIO to Participate in Upcoming Investor Conferences
INO - INOVIO to Participate in Upcoming Investor Conferences
EQUITY | Sep 01, 2026, 08:06 PM UTC
L
INO Reports Q2 2026 Financial Results
INO reports second quarter 2026 financial results and recent business highlights
EARNINGS | Aug 12, 2026, 08:06 PM UTC
L
INO INO - INOVIO to Report Second Quarter Financial Results on August 12, 2026
INO INO - INOVIO to Report Second Quarter Financial Results on August 12, 2026
EARNINGS | Aug 04, 2026, 08:05 PM UTC
H
Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 600 points on Thursday. Following the market opening Thursday, the Dow traded up 0.69% to 51,951.16 while the NASDAQ surged 2.54% to 25,
EARNINGS | Jul 30, 2026, 02:05 PM UTC
L
Deals priced today • JMKE (Jersey Mike’s Subs) 43.48M share IPO, priced at $23.00 (range was $21 - $25), by MSCO, JEFF, JPMC, BARC, GUGG, BA
Deals priced today • JMKE (Jersey Mike’s Subs) 43.48M share IPO, priced at $23.00 (range was $21 - $25), by MSCO, JEFF, JPMC, BARC, GUGG, BAML, GSCO, Evercore, UBS, B*ird, WELLS, WBLR, Nomura, Piper, RAJA, Stifel, TD, BT
EQUITY | Jul 30, 2026, 12:04 PM UTC
L
Multiple Companies: File Forms
Multiple companies file forms with regulators
FX | Jul 30, 2026, 09:42 AM UTC
H
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Shares of Microsoft Corp (NASDAQ: MSFT ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Microsoft reported fourth-quarter revenue of $90.01 billion, u
EARNINGS | Jul 30, 2026, 08:30 AM UTC
L
Multiple Companies File Forms
Multiple companies file forms with regulators
FX | Jul 30, 2026, 04:17 AM UTC
M
INOVIO prices $20M public offering
INOVIO prices public offering
EQUITY | Jul 30, 2026, 12:54 AM UTC
L
INO Inovio announces common stock and warrants offering, no amount given
INO Inovio announces common stock and warrants offering, no amount given
EQUITY | Jul 29, 2026, 08:05 PM UTC
H
Inovio Proposes Public Offering
Inovio proposes public offering
EQUITY | Jul 29, 2026, 08:01 PM UTC
L
Inovio Pharmaceuticals Files $300 Million Mixed Shelf Offering
() -- Inovio Pharmaceuticals (INO) filed a shelf registration to offer up to $300 million in a mix of securities, including common and preferred stock, debt securities, and warrants. Proceeds may be used for working capi
EQUITY | Jul 02, 2026, 09:19 PM UTC
L
Inovio Pharmaceuticals May Offer Up To $300 Mln Of Securities
Sec Filing
REGULATION | Jul 02, 2026, 08:09 PM UTC
L
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over
EQUITY | Jul 02, 2026, 01:18 PM UTC